Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.
about
Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review StudyCan Aliskiren be Considered as a New Novel Drug for Hypertension?Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.Prevalence of cognitive impairment no dementia in a rural area of Northern ChinaUptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis.Identifying predictors of blood pressure control in the Lebanese population - a national, multicentric survey -- I-PREDICT.Racial/Ethnic differences in medication uptake and clinical outcomes among hospitalized cardiovascular patients with hypertension and diabetesThe effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms.In vivo creatine kinase reaction kinetics at rest and stress in type II diabetic rat heart.Renin inhibitors in diabetes and hypertension: an update.Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes.Dietary Sodium Intake in Type 2 Diabetes.Association of blood glucose level and hypertension in Elderly Chinese Subjects: a community based studyCost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China.Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009.Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortalityEffect of exercise on blood pressure in type 2 diabetes: a randomized controlled trial.Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.Diabetes mellitus and vascular diseaseEffects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report.Predictors of all-cause and cardiovascular-specific mortality in type 2 diabetes: A competing risk modeling of an Iranian population.Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes.Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population.24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study.Does socioeconomic status or acculturation modify the association between ethnicity and hypertension treatment before stroke?Type 2 diabetes mellitus and hypertension: an update.Intrinsic disorder in biomarkers of insulin resistance, hypoadiponectinemia, and endothelial dysfunction among the type 2 diabetic patients.Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysisTreatment of hypertension in diabetes: what is the best therapeutic option?Treating hypertension in type 2 diabetes.The potential role of sodium glucose co-transporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.High Blood Pressure in Sub-Saharan Africa: Why Prevention, Detection, and Control are Urgent and Important.Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes.Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.ON NO--the continuing story of nitric oxide, diabetes, and cardiovascular disease.Hypertension revisited.Health behaviors for hypertension management in people with and without coexisting diabetes.[Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].
P2860
Q26740629-FC5B5037-095F-4D88-8482-5383CD21BB61Q26775106-C3448C56-1FFD-4A91-894E-61FD9C0EB45FQ33706621-780CB379-CD27-43A2-BA98-D8CF184F4662Q33818750-B56B0A1A-BD0B-40EC-830E-E752EDB566D1Q34555388-3E2EEB2F-6501-4626-8367-BF3D06E49AE8Q34582437-768D66AA-877A-4A81-89EA-3A438E77EFC8Q35055334-B5B36EDA-E865-43D2-BE26-3B2C98C6AC9EQ35178316-2BBEA402-2A5C-4D07-80F5-7495F52FACF2Q35294180-877451EB-52CE-4BA3-985A-5747DB2F1483Q35728190-B240E1E0-678A-4405-884F-BFC5A0C695DDQ35885368-0BEC232C-95D2-4289-B8A9-949EF8480555Q35906529-BF95A14F-214D-46AB-9247-DF86ACA266DAQ36076636-5016475E-159A-4338-BE49-BAA69DE1C01CQ36180337-C2112DE5-317D-4221-8D63-CFC1FF121006Q36209512-AEC0E5BC-06A0-4A05-B1D6-992DCF8A6248Q36288833-41989AC3-03D0-44D3-A37C-0815BF4F8500Q36331462-5208B7A3-993A-4FC9-9DD9-F4189FCA1892Q36373025-0166B8D8-FDDC-4670-9437-394EF10427E8Q36829126-02BD1400-83FF-4E5F-9377-56316C9AA585Q36874242-06A7D5E4-9B90-443C-934C-F2435C507DE8Q36934730-60459EF3-73DA-4693-8779-BAF37B853007Q37100325-A933B813-16DE-4D8C-81F4-592BD0E19C3DQ37152130-BDB9BF16-B2F9-4A49-AF96-B0304930D1CFQ37153153-8E5E6E1C-C491-40BC-A034-31F582021CEFQ37588809-EF9B8823-F444-43D4-A4F4-FC33E556CB18Q37617567-52095E50-0230-4347-856B-2DA37DC7994CQ37649609-0EA83614-A98C-4975-97CA-EC4C7BC1F784Q37668253-E9EECF35-CFA1-45FB-BEF5-6A48856AA106Q38034806-33D4BDBF-ED31-44C3-A91B-6E9FC316DAA7Q38236013-25CAB3FA-B435-449B-A049-F90F4226341EQ38260353-6AF322E3-1489-4CD0-83F8-A4534F608DDAQ38272734-0E0E19EF-96E1-4754-9D98-756E3BEBDEB2Q38658492-530FEFBE-9781-41D5-8B80-E15074FE4E3AQ38930353-DA7B3F17-A674-4614-B151-BD4468EAF9F1Q39000603-E4D2EB3C-66C3-48C4-855C-D0329AEE4549Q42434705-320314D0-0768-4FA6-9C4F-19E90C5DFF56Q43083132-9E90A92D-B874-47A6-880E-5EB65A35679FQ43197890-C9911771-7D6B-43AA-B725-FB27C3A0C50FQ43844178-6222AA4C-1DB0-42B7-97DC-200F1AB78161Q43981382-964D3E3C-3CD1-4871-8680-1D60B9A7EAD0
P2860
Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular outcomes in fra ...... importance of blood pressure.
@en
Cardiovascular outcomes in fra ...... importance of blood pressure.
@nl
type
label
Cardiovascular outcomes in fra ...... importance of blood pressure.
@en
Cardiovascular outcomes in fra ...... importance of blood pressure.
@nl
prefLabel
Cardiovascular outcomes in fra ...... importance of blood pressure.
@en
Cardiovascular outcomes in fra ...... importance of blood pressure.
@nl
P2093
P2860
P1433
P1476
Cardiovascular outcomes in fra ...... e importance of blood pressure
@en
P2093
Brenda R Hemmelgarn
Guanmin Chen
Norm R C Campbell
Robin L Walker
P2860
P304
P356
10.1161/HYPERTENSIONAHA.110.162446
P407
P577
2011-03-14T00:00:00Z